A detailed history of Los Angeles Capital Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 615,498 shares of ABBV stock, worth $123 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares
615,498
Previous 233,256 163.87%
Holding current value
$123 Million
Previous $40 Million 203.81%
% of portfolio
0.49%
Previous 0.14%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$163.84 - $199.33 $62.6 Million - $76.2 Million
382,242 Added 163.87%
615,498 $122 Million
Q2 2024

Aug 05, 2024

BUY
$154.79 - $180.76 $10.1 Million - $11.7 Million
64,979 Added 38.61%
233,256 $40 Million
Q1 2024

Apr 05, 2024

SELL
$159.82 - $182.1 $23.6 Million - $26.9 Million
-147,843 Reduced 46.77%
168,277 $30.6 Million
Q4 2023

Feb 06, 2024

BUY
$137.6 - $154.97 $17.8 Million - $20 Million
129,355 Added 69.26%
316,120 $49 Million
Q3 2023

Nov 06, 2023

SELL
$133.59 - $154.65 $1.1 Million - $1.27 Million
-8,209 Reduced 4.21%
186,765 $27.8 Million
Q2 2023

Aug 03, 2023

SELL
$132.51 - $164.9 $26.7 Million - $33.2 Million
-201,509 Reduced 50.82%
194,974 $26.3 Million
Q1 2023

May 04, 2023

SELL
$144.61 - $166.54 $43.6 Million - $50.2 Million
-301,332 Reduced 43.18%
396,483 $63.2 Million
Q4 2022

Feb 06, 2023

SELL
$138.31 - $165.87 $36.3 Million - $43.5 Million
-262,465 Reduced 27.33%
697,815 $113 Million
Q3 2022

Nov 02, 2022

SELL
$134.21 - $153.93 $35.9 Million - $41.2 Million
-267,643 Reduced 21.8%
960,280 $129 Million
Q2 2022

Aug 05, 2022

SELL
$137.62 - $174.96 $6.51 Million - $8.27 Million
-47,277 Reduced 3.71%
1,227,923 $188 Million
Q1 2022

May 06, 2022

BUY
$131.98 - $163.75 $45.5 Million - $56.4 Million
344,372 Added 37.0%
1,275,200 $207 Million
Q4 2021

Feb 03, 2022

BUY
$107.43 - $135.93 $15 Million - $19 Million
139,931 Added 17.69%
930,828 $126 Million
Q3 2021

Nov 08, 2021

SELL
$106.4 - $120.78 $12.7 Million - $14.4 Million
-118,892 Reduced 13.07%
790,897 $85.3 Million
Q2 2021

Aug 05, 2021

SELL
$105.21 - $117.21 $5.92 Million - $6.59 Million
-56,245 Reduced 5.82%
909,789 $102 Million
Q1 2021

May 05, 2021

SELL
$102.3 - $112.62 $2.26 Million - $2.49 Million
-22,116 Reduced 2.24%
966,034 $105 Million
Q4 2020

Feb 04, 2021

SELL
$80.49 - $108.67 $14.1 Million - $19.1 Million
-175,466 Reduced 15.08%
988,150 $106 Million
Q3 2020

Nov 02, 2020

SELL
$85.91 - $100.83 $107 Million - $126 Million
-1,245,840 Reduced 51.71%
1,163,616 $102 Million
Q2 2020

Aug 05, 2020

BUY
$73.37 - $98.18 $46.7 Million - $62.5 Million
636,292 Added 35.88%
2,409,456 $237 Million
Q1 2020

May 04, 2020

SELL
$64.5 - $97.79 $122 Million - $185 Million
-1,892,919 Reduced 51.63%
1,773,164 $135 Million
Q4 2019

Feb 07, 2020

BUY
$72.13 - $90.25 $101 Million - $127 Million
1,405,797 Added 62.2%
3,666,083 $325 Million
Q3 2019

Nov 07, 2019

BUY
$62.98 - $75.72 $102 Million - $122 Million
1,612,889 Added 249.13%
2,260,286 $171 Million
Q2 2019

Jul 29, 2019

SELL
$65.7 - $83.98 $9.01 Million - $11.5 Million
-137,189 Reduced 17.49%
647,397 $47.1 Million
Q1 2019

Apr 25, 2019

SELL
$77.14 - $90.79 $14.4 Million - $16.9 Million
-186,670 Reduced 19.22%
784,586 $63.2 Million
Q4 2018

Feb 11, 2019

BUY
$77.85 - $96.01 $26.2 Million - $32.4 Million
337,004 Added 53.13%
971,256 $89.5 Million
Q3 2018

Nov 05, 2018

SELL
$88.91 - $98.84 $17.7 Million - $19.7 Million
-199,300 Reduced 23.91%
634,252 $60 Million
Q2 2018

Jul 31, 2018

SELL
$89.78 - $106.23 $7.83 Million - $9.27 Million
-87,259 Reduced 9.48%
833,552 $77.2 Million
Q1 2018

Apr 27, 2018

BUY
$92.01 - $123.21 $53.1 Million - $71.1 Million
576,810 Added 167.68%
920,811 $87.2 Million
Q4 2017

Feb 05, 2018

SELL
$89.56 - $98.21 $36.5 Million - $40 Million
-407,229 Reduced 54.21%
344,001 $33.3 Million
Q3 2017

Nov 06, 2017

BUY
$69.85 - $89.22 $757,034 - $966,966
10,838 Added 1.46%
751,230 $66.8 Million
Q2 2017

Aug 09, 2017

BUY
N/A
740,392
740,392 $53.7 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $355B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.